APA (7th ed.) Citation

Tanabe, Y., Inoue, K., Takahashi, M., Mukai, H., Yamanaka, T., Egawa, C., . . . Tsurutani, J. (2025). Prognosis of Invasive Lobular Carcinoma and Effectiveness of Eribulin in Clinical Practice: A Post Hoc Analysis of a 2‐Year Post‐Marketing Surveillance. Asia Pacific Journal of Clinical Oncology, 21(6), 623. https://doi.org/10.1111/ajco.14189

Chicago Style (17th ed.) Citation

Tanabe, Yuko, et al. "Prognosis of Invasive Lobular Carcinoma and Effectiveness of Eribulin in Clinical Practice: A Post Hoc Analysis of a 2‐Year Post‐Marketing Surveillance." Asia Pacific Journal of Clinical Oncology 21, no. 6 (2025): 623. https://doi.org/10.1111/ajco.14189.

MLA (9th ed.) Citation

Tanabe, Yuko, et al. "Prognosis of Invasive Lobular Carcinoma and Effectiveness of Eribulin in Clinical Practice: A Post Hoc Analysis of a 2‐Year Post‐Marketing Surveillance." Asia Pacific Journal of Clinical Oncology, vol. 21, no. 6, 2025, p. 623, https://doi.org/10.1111/ajco.14189.